top of page

Profile
Join date: Jul 4, 2023
Posts (11)
Nov 7, 2025 ∙ 1 min
Azome Therapeutics Presents at 7th Annual Inflammasome Therapeutics Summit
November 6, 2025 Azome Therapeutics CEO Elliott Gruskin and the Head of the company’s Scientific Advisory Board Rashmin Savani were among the expert speakers at the 7 th Annual Inflammasome Therapeutics Summit – the leading industry forum dedicated exclusively to inflammasome-targeted drug development – held November 4-6 in Boston, MA As one of the summit’s keynote speakers, Dr. Savani discussed the development of the company’s novel RHAMM-targeted antagonist technology. His presentation...
123
0
Oct 9, 2025 ∙ 2 min
Azome Therapeutics Featured at Hyaluronan 2025
October 9, 2025 Dr. Rashmin Savani, the Head of Azome Therapeutic’s Scientific Advisory Board, was a featured speaker at this summer’s...
489
0
Nov 13, 2024 ∙ 2 min
Azome Therapeutics Enters into CRADA with National Center for Advancing Translational Sciences to investigate novel inflammasome antagonist to prevent Bronchopulmonary Dysplasia
Collaboration focuses on studies of AZM-152 to enable submission of an Investigational New Drug (IND) application for the prevention of...
149
0
N-Vision Accounts
Admin
More actions
bottom of page
